KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Receivables: 2009-2024

Historic Change in Receivables for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to $24.4 million.

  • Emergent BioSolutions' Change in Receivables rose 187.00% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.5 million, marking a year-over-year increase of 215.51%. This contributed to the annual value of $24.4 million for FY2024, which is 12.96% up from last year.
  • Emergent BioSolutions' Change in Receivables amounted to $24.4 million in FY2024, which was up 12.96% from $21.6 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Change in Receivables registered a high of $24.4 million during FY2024, and its lowest value of -$118.1 million during FY2022.
  • Over the past 3 years, Emergent BioSolutions' median Change in Receivables value was $21.6 million (recorded in 2023), while the average stood at -$24.0 million.
  • Per our database at Business Quant, Emergent BioSolutions' Change in Receivables soared by 158.91% in 2021 and then crashed by 829.01% in 2022.
  • Over the past 5 years, Emergent BioSolutions' Change in Receivables (Yearly) stood at -$27.5 million in 2020, then soared by 158.91% to $16.2 million in 2021, then slumped by 829.01% to -$118.1 million in 2022, then spiked by 118.29% to $21.6 million in 2023, then climbed by 12.96% to $24.4 million in 2024.